Reproductive Assessment Flashcards
changes in the reproductive system related to females
graying and thinning of pubic hair
decreased size of the labia majora and clitoris
drying, smoothing, and thinning of vaginal walls
decrease size of the uterus
atrophy of the endometrium
decrease size and marked convolution of the ovaries
loss of tone and elasticity of the pelvic ligaments and connective tissue
increased flabbiness and fibrosis of the breasts, which hang lower on the chest wall; decreased erection of nipples
changes in reproductive system related to males
graying and thinning of pubic hair
increased drooping in the scrotum and loss of rugae
prostate enlargement, with an increased likelihood of urethral obstruction
nutrition history assessment collected for reproductive system
high alcohol intake increases risk of ovarian cancer
diet high in fat and low in fruits and vegetables increase risk of reproductive cancers
ex: prostate and ovarian cancer
family history and genetic risk assessment collected for reproductive system
daughters of women given diethylstilbestrol (DES) to control bleeding during pregnancy are at increased risk for infertility and reproductive tract cancer
specific BRCA 1 and BRCA 2 gene mutations increase overall risk for breast or ovarian cancer
men with first degree relatives (father, brother) with prostate cancer are at greater risk
physical assessment for reproductive system
focused assessment related to specific concerns and needs of the patient
current health problems: pain, bleeding, discharge, masses
Labs for female reproductive
Pap smear
HPV
Vaginal cultures
alpha fetoprotein (AFP)
cancer antigen 125 (CA 125)
Pap smear
cytologic study effective in detecting precancerous and cancerous cells from the cervix
Annual pap smear starting at age 21
HPV
used to identify many high risk types of HPV associated with the development of cervical cancer
cells are collected from the cervix at the same time a pap test is completed
vaginal cultures
used to detect bacterial, viral, fungal, and parasitic disorders
AFP
elevated with ovarian cancer
Cancer antigen CA 125
elevated with ovarian cancer
Labs for male reproductive
prostate specific antigen (PSA) test, early prostate cancer antigen (EPCA-2) and serum acid phosphate, alpha fetoprotein (AFP), beta human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH)
Prostate specific antigen (PSA) test
normal less than 2.5 ng/ml for age 50 and increases with age (possibly up to 6.5 ng/ml)
used as a screening lab for prostate cancer because other prostate problems can increase the level
some variance on the PSA value and how it is affected by age
early prostate cancer antigen (EPCA-2) and serum acid phosphate
elevations indicative of prostate cancer
EPCA-2 is very sensitive and can detect early
alpha fetoprotein (AFP), beta human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH)
elevations indicative of testicular cancer
Imaging for reproductive system
CT, MRI, Ultrasonography, hysterosalpingography, mammogram
CT Reproductive
evaluate for metastasis with different reproductive cancers, evaluate for ovarian cancer
MRI reproductive
evaluation for breast cancer for women with high risk factors
ultrasonography reproductive
transvaginal- ovarian and endometrial cancer
transrectal- prostate cancer
ultrasound- evaluate for testicular masses versus fluid
also used for breast cancer evaluation
hystersalpingography (HSG)
x ray that uses an injection of a contrast medium to visualize the cervix, uterus, and fallopian tubes
used to evaluate tubal anatomy and patency and uterine problems such as fibroids, tumors, and fistulas
“pre” considerations for HSG
assess for allergies to contrast dye
“post” considerations for HSG
some pelvic and referred shoulder pain